European Pharma’s U.S. Market Exposure & Pricing Risks
The Transatlantic Dependency: A Double-Edged Sword For decades, the United States has served as the primary engine of growth for the European pharmaceutical industry. With a healthcare system that has historically favored innovation through high drug pricing and robust patent […]
European Pharma’s U.S. Market Exposure & Pricing Risks Read More »